Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver Howes, John M. Kane, David Castle et al.|American Journal of Psychiatry|2016Cited by 1.1k
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaTristram A. Lett, Aristotle N. Voineskos, M M Chakavarty et al.|Molecular Psychiatry|2013Cited by 119
Clozapine Acts as an Agonist at Serotonin 2A Receptors to Counter MK-801-Induced Behaviors through a βArrestin2-Independent Activation of AktCullen L. Schmid, Laura Bohn, John M. Streicher et al.|Neuropsychopharmacology|2014Cited by 65
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-AnalysisEric Yi‐Hsiu Huang, James Kennedy, Clement C. Zai et al.|The International Journal of Neuropsychopharmacology|2016Cited by 64
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider‐Thoma, Stefan Leucht, Tasnim Hamza et al.|The Lancet Psychiatry|2025Cited by 26